Hainan Haiyao Co., Ltd. (SHE:000566)

China flag China · Delayed Price · Currency is CNY
5.74
-0.01 (-0.17%)
Mar 10, 2026, 3:04 PM CST
14.34%
Market Cap 7.45B
Revenue (ttm) 825.66M
Net Income (ttm) -1.47B
Shares Out 1.30B
EPS (ttm) -1.14
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 25,219,126
Average Volume 37,444,065
Open 5.63
Previous Close 5.74
Day's Range 5.63 - 5.80
52-Week Range 3.76 - 9.24
Beta 0.44
RSI 35.23
Earnings Date Apr 11, 2026

About Hainan Haiyao

Hainan Haiyao Co., Ltd. manufactures and sells pharmaceutical products and medical devices in China and internationally. The company offers intermediates, active pharmaceutical ingredients (APIs), innovative chemical drugs, modern traditional Chinese medicine, biopharmaceuticals, cell immunotherapy, and medical devices, as well as big health category products, digestive and anti-infective products, breathing products, anti-tumor products, chronic disease category products, vitamins, Chinese herbal medicine slices, and medical services. Hainan H... [Read more]

Sector Healthcare
Founded 1965
Employees 2,003
Stock Exchange Shenzhen Stock Exchange
Ticker Symbol 000566
Full Company Profile

Financial Performance

In 2024, Hainan Haiyao's revenue was 990.70 million, a decrease of -33.00% compared to the previous year's 1.48 billion. Losses were -1.53 billion, 1332.3% more than in 2023.

Financial Statements

News

There is no news available yet.